English
简体中文
Total: £ 56.28
Published Date: 2025-06-13 | Pages: 132 | Tables: 144 | Medical Care
In 2024, the global market size of Biological Indicators was estimated to be worth US$ 411 million and is forecast to reach approximately US$ 610 million by 2031 with a CAGR of 5.9% during the forecast period 2025-2031.
Biological indicators (BIs), as defined by ANSI/AAMI and ISO, are test systems containing viable microorganisms providing a defined resistance to a specific sterilization process. A biological indicator provides information on whether necessary conditions were met to kill a specified number of microorganisms for a given sterilization process, providing a level of confidence in the process.
Biological Indicators (BIs) play a critical role in sterilization validation and infection control, widely used in medical devices, pharmaceuticals, food processing, and life sciences laboratories. They assess the effectiveness of steam, dry heat, ethylene oxide (EO), hydrogen peroxide, and other sterilization methods, ensuring compliance with ISO 11138, USP, and FDA regulations.
Based on form factor, BIs can be categorized into Self-Contained Biological Indicators (SCBIs), BI Strips, and BI Suspensions. Among them, SCBIs are widely used due to their convenience, reduced contamination risk, and enhanced validation efficiency.
In terms of application, the medical sector dominates the market, as hospitals and medical device manufacturers must routinely validate sterilization equipment like autoclaves and plasma sterilizers. The pharmaceutical industry also has stringent requirements for sterilization, especially in injectable drugs, vaccines, and sterile drug production. Additionally, the food and beverage sector is increasingly adopting BIs to monitor sterilization efficiency in processing equipment, ensuring food safety and regulatory compliance.
Regionally, North America is the largest market, with a share nearly 55%. North America and Europe lead the market due to stringent medical regulations and high industry standards. The Asia-Pacific region (especially China and India) is experiencing rapid growth in the BI market, driven by expanding healthcare and pharmaceutical industries and evolving regulatory frameworks. Latin America and the Middle East are also emerging markets, benefiting from improvements in healthcare infrastructure.
Looking ahead, the BI industry is shifting toward more efficient, intelligent, and automated solutions. Rapid-read BIs, electronic BIs (E-BIs), and smart monitoring systems are gradually replacing traditional methods, reducing manual intervention, accelerating sterilization validation, and improving quality control. As pharmaceutical regulations tighten and medical device standards advance, the demand for BIs is expected to rise, ensuring a more reliable approach to sterilization validation and infection control worldwide.
Report Scope
This report aims to provide a comprehensive presentation of the global market for Biological Indicators, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Biological Indicators.
The Biological Indicators market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Biological Indicators market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Biological Indicators companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, product type, application, and regions.
Market Segmentation
By Company
3M
Getinge Group
Cantel Medical
Mesa Laboratories
Steris
Fuze Medical
Matachana
Hu-Friedy
Advanced Sterilization
Bag Health Care
Terragene
Andersen
GKE
Segment by Type
Self-Contained Biological Indicator
Biological Indicator Strip
Others
Segment by Application
Hospital
Pharma Companies
Others
By Region
North America
United States
Canada
Asia-Pacific
China
Japan
South Korea
India
Southeast Asia
Australia
Rest of Asia-Pacific
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Rest of Europe
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on.
Chapter 2: Revenue of Biological Indicators in global and regional level.
Chapter 3: Detailed analysis of Biological Indicators company competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Biological Indicators revenue, gross margin, and recent development, etc.
Chapter 5: Provides the analysis of various market segments by Type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 6: Provides the analysis of various market segments by Application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 7: North America (US & Canada) by Type, by Application and by country, revenue for each segment.
Chapter 8: Europe by Type, by Application and by country, revenue for each segment.
Chapter 9: Asia Pacific by Type, by Application and by region, revenue for each segment.
Chapter 10: Latin America by Type, by Application and by country, revenue for each segment.
Chapter 11: Middle East and Africa, by Type, by Application and by country, revenue for each segment.
Chapter 12: Analysis of industrial chain, sales channel, key raw materials, distributors, and customers.
Chapter 13: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 14: Research Findings and Conclusion
Research Methodology
The research methodology employed has been subjected by numerous procedures in order to guarantee the quality and accuracy of the data contained within the reports. The analysts are employed full-time and received more than six months training to satisfy the standard of our company. Our methodology can be divided into five stages:
★Stage 1 SECONDARY RESEARCH
The research team first collaborates with magazines, trade associations and administrative departments in the research field. The information provided by our internal documentation service is helpful for our further research. Our team has a wealth of experience and knowledge, and can effectively extract accurate information from existing resources.
★Stage 2 PRIMARY RESEARCH:INTERVIEWS WITH TRADE SOURCES
After the first stage, the research team conducts a large number of face-to-face or telephone interviews with representative companies working in the research field. Analysts are trying to have an opportunity to talk to leading companies and small companies in the field. Upstream suppliers, manufacturers, distributors, importers, installers, wholesalers and consumers were included in the interview. The data collected during the interview were then carefully examined and compared with the secondary study.
★Stage 3 ANALYSIS OF THE GATHERED DATA
The analysis team examines and synthesizes the data collected in the first two stages. In order to validate the data, a second round of interviews can be conducted.
★Stage 4 QUANTITATIVE DATA
The quantitative data such as market estimates, production and capacity of manufacturer, market forecasts and investment feasibility is provided by our company. The data is based on the estimates obtained during stage 3.
★Stage 5 QUALITY CONTROL
Before publishing, each report undergoes a rigorous review and editing process, which is done by the experience management team to ensure the reliability of the published data. Every analyst on the research team receives support and continuous training as part of our internal quality process.
1 Study Coverage
1.1 Biological Indicators Product Introduction
1.2 Market by Type
1.2.1 Global Biological Indicators Market Size Growth Rate by Type (2020 VS 2024 VS 2031)
1.2.2 Self-Contained Biological Indicator
1.2.3 Biological Indicator Strip
1.3 Market by Application
1.3.1 Global Biological Indicators Market Size Growth Rate by Application (2020 VS 2024 VS 2031)
1.3.2 Hospital
1.3.3 Pharma Companies
1.3.4 Others
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Executive Summary
2.1 Global Biological Indicators Market Size Estimates and Forecasts
2.2 Biological Indicators Market Size by Region: 2024 Versus 2031
2.2.1 Global Biological Indicators Revenue by Region: 2020-2025
2.2.2 Global Biological Indicators Revenue Forecast by Region (2026-2031)
2.2.3 Global Biological Indicators Revenue Market Share by Region (2020-2031)
3 Market Segments
3.1 Breakdown Data by Type
3.1.1 Global Biological Indicators Revenue by Type (2020-2031)
3.1.2 Global Biological Indicators Revenue Market Share by Type (2020-2031)
3.2 Breakdown Data by Application
3.2.1 Global Biological Indicators Revenue by Application (2020-2031)
3.2.2 Global Biological Indicators Revenue Market Share by Application (2020-2031)
3.3 by Type and by Application Crossing Analysis
3.3.1 Self-Contained Biological Indicator of Biological Indicators Revenue Market Share by Application
3.3.2 Biological Indicator Strip of Biological Indicators Revenue Market Share by Application
4 Global Biological Indicators by Company
4.1 Global Biological Indicators Revenue by Company (2020-2025)
4.2 Global Biological Indicators Revenue Share by Company (2020-2025)
4.3 Competitive Landscape
4.3.1 Key Biological Indicators Companies around the World: Ranking by Revenue
4.3.2 Global Biological Indicators Market Concentration Ratio (CR5 and HHI) & (2020-2025)
4.3.3 Global Biological Indicators Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
4.4 Global Biological Indicators Companies Headquarters & Product Type
4.4.1 Global Biological Indicators Companies Headquarters
4.4.2 Date of International Companies Enter into Biological Indicators Market
4.4.3 Global Biological Indicators Companies Product & Service
4.4.4 Self-Contained Biological Indicator Revenue Market Share of Biological Indicators by Company
4.4.5 Biological Indicator Strip Revenue Market Share of Biological Indicators by Company
4.5 Global Biological Indicators Mergers & Acquisitions, Expansion Plans
5 Company Profiles
5.1 3M
5.1.1 3M Corporation Information
5.1.2 3M Description, Business Overview
5.1.3 3M Biological Indicators Products Offered
5.1.4 3M Biological Indicators Revenue and Gross Margin (2020-2025)
5.1.5 3M Biological Indicators Revenue by Product in 2024
5.1.6 3M Biological Indicators Revenue by Application in 2024
5.1.7 3M Biological Indicators Revenue by Geographic Area in 2024
5.1.8 3M Recent Developments
5.2 Getinge Group
5.2.1 Getinge Group Corporation Information
5.2.2 Getinge Group Description, Business Overview
5.2.3 Getinge Group Biological Indicators Products Offered
5.2.4 Getinge Group Biological Indicators Revenue and Gross Margin (2020-2025)
5.2.5 Getinge Group Biological Indicators Revenue by Product in 2024
5.2.6 Getinge Group Biological Indicators Revenue by Application in 2024
5.2.7 Getinge Group Biological Indicators Revenue by Geographic Area in 2024
5.2.8 Getinge Group Recent Developments
5.3 Cantel Medical
5.3.1 Cantel Medical Corporation Information
5.3.2 Cantel Medical Description, Business Overview
5.3.3 Cantel Medical Biological Indicators Products Offered
5.3.4 Cantel Medical Biological Indicators Revenue and Gross Margin (2020-2025)
5.3.5 Cantel Medical Biological Indicators Revenue by Product in 2024
5.3.6 Cantel Medical Biological Indicators Revenue by Application in 2024
5.3.7 Cantel Medical Biological Indicators Revenue by Geographic Area in 2024
5.3.8 Cantel Medical Recent Developments
5.4 Mesa Laboratories
5.4.1 Mesa Laboratories Corporation Information
5.4.2 Mesa Laboratories Description, Business Overview
5.4.3 Mesa Laboratories Biological Indicators Products Offered
5.4.4 Mesa Laboratories Biological Indicators Revenue and Gross Margin (2020-2025)
5.4.5 Mesa Laboratories Biological Indicators Revenue by Product in 2024
5.4.6 Mesa Laboratories Biological Indicators Revenue by Application in 2024
5.4.7 Mesa Laboratories Biological Indicators Revenue by Geographic Area in 2024
5.4.8 Mesa Laboratories Recent Developments
5.5 Steris
5.5.1 Steris Corporation Information
5.5.2 Steris Description, Business Overview
5.5.3 Steris Biological Indicators Products Offered
5.5.4 Steris Biological Indicators Revenue and Gross Margin (2020-2025)
5.5.5 Steris Biological Indicators Revenue by Product in 2024
5.5.6 Steris Biological Indicators Revenue by Application in 2024
5.5.7 Steris Biological Indicators Revenue by Geographic Area in 2024
5.5.8 Steris Recent Developments
5.6 Fuze Medical
5.6.1 Fuze Medical Corporation Information
5.6.2 Fuze Medical Description, Business Overview
5.6.3 Fuze Medical Biological Indicators Products Offered
5.6.4 Fuze Medical Biological Indicators Revenue and Gross Margin (2020-2025)
5.6.5 Fuze Medical Biological Indicators Revenue by Product in 2024
5.6.6 Fuze Medical Biological Indicators Revenue by Application in 2024
5.6.7 Fuze Medical Biological Indicators Revenue by Geographic Area in 2024
5.6.8 Fuze Medical Recent Developments
5.7 Matachana
5.7.1 Matachana Corporation Information
5.7.2 Matachana Description, Business Overview
5.7.3 Matachana Biological Indicators Products Offered
5.7.4 Matachana Biological Indicators Revenue and Gross Margin (2020-2025)
5.7.5 Matachana Biological Indicators Revenue by Product in 2024
5.7.6 Matachana Biological Indicators Revenue by Application in 2024
5.7.7 Matachana Biological Indicators Revenue by Geographic Area in 2024
5.7.8 Matachana Recent Developments
5.8 Hu-Friedy
5.8.1 Hu-Friedy Corporation Information
5.8.2 Hu-Friedy Description, Business Overview
5.8.3 Hu-Friedy Biological Indicators Products Offered
5.8.4 Hu-Friedy Biological Indicators Revenue and Gross Margin (2020-2025)
5.8.5 Hu-Friedy Biological Indicators Revenue by Product in 2024
5.8.6 Hu-Friedy Biological Indicators Revenue by Application in 2024
5.8.7 Hu-Friedy Biological Indicators Revenue by Geographic Area in 2024
5.8.8 Hu-Friedy Recent Developments
5.9 Advanced Sterilization
5.9.1 Advanced Sterilization Corporation Information
5.9.2 Advanced Sterilization Description, Business Overview
5.9.3 Advanced Sterilization Biological Indicators Products Offered
5.9.4 Advanced Sterilization Biological Indicators Revenue and Gross Margin (2020-2025)
5.9.5 Advanced Sterilization Biological Indicators Revenue by Product in 2024
5.9.6 Advanced Sterilization Biological Indicators Revenue by Application in 2024
5.9.7 Advanced Sterilization Biological Indicators Revenue by Geographic Area in 2024
5.9.8 Advanced Sterilization Recent Developments
5.10 Bag Health Care
5.10.1 Bag Health Care Corporation Information
5.10.2 Bag Health Care Description, Business Overview
5.10.3 Bag Health Care Biological Indicators Products Offered
5.10.4 Bag Health Care Biological Indicators Revenue and Gross Margin (2020-2025)
5.10.5 Bag Health Care Biological Indicators Revenue by Product in 2024
5.10.6 Bag Health Care Biological Indicators Revenue by Application in 2024
5.10.7 Bag Health Care Biological Indicators Revenue by Geographic Area in 2024
5.10.8 Bag Health Care Recent Developments
5.11 Terragene
5.11.1 Terragene Corporation Information
5.11.2 Terragene Description, Business Overview
5.11.3 Terragene Biological Indicators Products Offered
5.11.4 Terragene Biological Indicators Revenue and Gross Margin (2020-2025)
5.11.5 Terragene Biological Indicators Revenue by Product in 2024
5.11.6 Terragene Biological Indicators Revenue by Application in 2024
5.11.7 Terragene Biological Indicators Revenue by Geographic Area in 2024
5.11.8 Terragene Recent Developments
5.12 Andersen
5.12.1 Andersen Corporation Information
5.12.2 Andersen Description, Business Overview
5.12.3 Andersen Biological Indicators Products Offered
5.12.4 Andersen Biological Indicators Revenue and Gross Margin (2020-2025)
5.12.5 Andersen Biological Indicators Revenue by Product in 2024
5.12.6 Andersen Biological Indicators Revenue by Application in 2024
5.12.7 Andersen Biological Indicators Revenue by Geographic Area in 2024
5.12.8 Andersen Recent Developments
5.13 GKE
5.13.1 GKE Corporation Information
5.13.2 GKE Description, Business Overview
5.13.3 GKE Biological Indicators Products Offered
5.13.4 GKE Biological Indicators Revenue and Gross Margin (2020-2025)
5.13.5 GKE Biological Indicators Revenue by Product in 2024
5.13.6 GKE Biological Indicators Revenue by Application in 2024
5.13.7 GKE Biological Indicators Revenue by Geographic Area in 2024
5.13.8 GKE Recent Developments
6 North America
6.1 North America Biological Indicators Market Size YoY Growth 2020-2031
6.2 North America Biological Indicators Market Facts & Figures by Country (2020-2031)
6.3 North America Biological Indicators Revenue by Type (2020-2025)
6.4 North America Biological Indicators Revenue by Application (2020-2025)
7 Asia-Pacific
7.1 Asia-Pacific Biological Indicators Market Size YoY Growth 2020-2031
7.2 Asia-Pacific Biological Indicators Market Facts & Figures by Region (2020-2031)
7.3 Asia-Pacific Biological Indicators Revenue by Type (2020-2025)
7.4 Asia-Pacific Biological Indicators Revenue by Application (2020-2025)
8 Europe
8.1 Europe Biological Indicators Market Size YoY Growth 2020-2031
8.2 Europe Biological Indicators Market Facts & Figures by Country (2020-2031)
8.3 Europe Biological Indicators Revenue by Type (2020-2025)
8.4 Europe Biological Indicators Revenue by Application (2020-2025)
9 Latin America
9.1 Latin America Biological Indicators Market Size YoY Growth 2020-2031
9.2 Latin America Biological Indicators Market Facts & Figures by Country (2020-2031)
9.3 Latin America Biological Indicators Revenue by Type (2020-2025)
9.4 Latin America Biological Indicators Revenue by Application (2020-2025)
10 Middle East and Africa
10.1 Latin America Biological Indicators Market Size YoY Growth 2020-2031
10.2 Middle East and Africa Biological Indicators Market Facts & Figures by Country (2020-2031)
10.3 Middle East and Africa Biological Indicators Revenue by Type (2020-2025)
10.4 Middle East and Africa Biological Indicators Revenue by Application (2020-2025)
11 Supply Chain and Sales Channel analysis
11.1 Biological Indicators Supply Chain Analysis
11.2 Biological Indicators Key Raw Materials and Upstream Suppliers
11.3 Biological Indicators Clients Analysis
11.4 Biological Indicators Sales Channel and Sales Model Analysis
11.4.1 Biological Indicators Distribution Channel Analysis: Indirect Sales VS Direct Sales
11.4.2 Biological Indicators Distribution Channel Analysis: Online Sales VS Offline Sales
11.4.3 Biological Indicators Distributors
12 Biological Indicators Market Dynamics
12.1 Biological Indicators Industry Trends
12.2 Biological Indicators Market Drivers
12.3 Biological Indicators Market Challenges
12.4 Biological Indicators Market Restraints
13 Research Findings and Conclusion
14 Appendix
14.1 Research Methodology
14.1.1 Methodology/Research Approach
14.1.1.1 Research Programs/Design
14.1.1.2 Market Size Estimation
14.1.1.3 Market Breakdown and Data Triangulation
14.1.2 Data Source
14.1.2.1 Secondary Sources
14.1.2.2 Primary Sources
14.2 Author Details
14.3 Disclaimer
List of Tables
Table 1. Global Biological Indicators Market Size Growth Rate (CAGR) by Type (US$ Million): 2020 VS 2024 VS 2031
Table 2. Global Biological Indicators Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031
Table 3. Global Biological Indicators Market Size by Region (US$ Million): 2024 VS 2031
Table 4. Global Biological Indicators Revenue by Region (2020-2025) & (US$ Million)
Table 5. Global Biological Indicators Revenue Forecast by Region (2026-2031) & (US$ Million)
Table 6. Global Biological Indicators Revenue by Type (2020-2025) & (US$ Million)
Table 7. Global Biological Indicators Revenue Forecast by Type (2026-2031) & (US$ Million)
Table 8. Global Biological Indicators Revenue by Application (2020-2025) & (US$ Million)
Table 9. Global Biological Indicators Revenue Forecast by Application (2026-2031) & (US$ Million)
Table 10. Biological Indicators Revenue by Company (2020-2025) & (US$ Million)
Table 11. Biological Indicators Revenue Share by Company (2020-2025)
Table 12. Ranking of Global Top Biological Indicators Players by Revenue (US$ Million) in 2024
Table 13. Global Biological Indicators Companies Market Concentration Ratio (CR5 and HHI) & (2020-2025)
Table 14. Global Biological Indicators by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Biological Indicators as of 2024)
Table 15. Global Biological Indicators Companies Headquarters
Table 16. Date of International Companies Enter into Biological Indicators Market
Table 17. Global Biological Indicators Companies Product & Service
Table 18. Global Biological Indicators Mergers & Acquisitions, Expansion Plans
Table 19. 3M Corporation Information
Table 20. 3M Description and Business Overview
Table 21. 3M Biological Indicators Product
Table 22. 3M Biological Indicators Revenue (US$ Million) and Gross Margin (2020-2025)
Table 23. 3M Revenue Proportion of Biological Indicators by Product in 2024
Table 24. 3M Revenue Proportion of Biological Indicators by Application in 2024
Table 25. 3M Revenue Proportion of Biological Indicators by Geographic Area in 2024
Table 26. 3M Recent Developments
Table 27. Getinge Group Corporation Information
Table 28. Getinge Group Description and Business Overview
Table 29. Getinge Group Biological Indicators Product
Table 30. Getinge Group Biological Indicators Revenue (US$ Million) and Gross Margin (2020-2025)
Table 31. Getinge Group Revenue Proportion of Biological Indicators by Product in 2024
Table 32. Getinge Group Revenue Proportion of Biological Indicators by Application in 2024
Table 33. Getinge Group Revenue Proportion of Biological Indicators by Geographic Area in 2024
Table 34. Getinge Group Recent Developments
Table 35. Cantel Medical Corporation Information
Table 36. Cantel Medical Description and Business Overview
Table 37. Cantel Medical Biological Indicators Product
Table 38. Cantel Medical Biological Indicators Revenue (US$ Million) and Gross Margin (2020-2025)
Table 39. Cantel Medical Revenue Proportion of Biological Indicators by Product in 2024
Table 40. Cantel Medical Revenue Proportion of Biological Indicators by Application in 2024
Table 41. Cantel Medical Revenue Proportion of Biological Indicators by Geographic Area in 2024
Table 42. Cantel Medical Recent Developments
Table 43. Mesa Laboratories Corporation Information
Table 44. Mesa Laboratories Description and Business Overview
Table 45. Mesa Laboratories Biological Indicators Product
Table 46. Mesa Laboratories Biological Indicators Revenue (US$ Million) and Gross Margin (2020-2025)
Table 47. Mesa Laboratories Revenue Proportion of Biological Indicators by Product in 2024
Table 48. Mesa Laboratories Revenue Proportion of Biological Indicators by Application in 2024
Table 49. Mesa Laboratories Revenue Proportion of Biological Indicators by Geographic Area in 2024
Table 50. Mesa Laboratories Recent Developments
Table 51. Steris Corporation Information
Table 52. Steris Description and Business Overview
Table 53. Steris Biological Indicators Product
Table 54. Steris Biological Indicators Revenue (US$ Million) and Gross Margin (2020-2025)
Table 55. Steris Revenue Proportion of Biological Indicators by Product in 2024
Table 56. Steris Revenue Proportion of Biological Indicators by Application in 2024
Table 57. Steris Revenue Proportion of Biological Indicators by Geographic Area in 2024
Table 58. Steris Recent Developments
Table 59. Fuze Medical Corporation Information
Table 60. Fuze Medical Description and Business Overview
Table 61. Fuze Medical Biological Indicators Product
Table 62. Fuze Medical Biological Indicators Revenue (US$ Million) and Gross Margin (2020-2025)
Table 63. Fuze Medical Revenue Proportion of Biological Indicators by Product in 2024
Table 64. Fuze Medical Revenue Proportion of Biological Indicators by Application in 2024
Table 65. Fuze Medical Revenue Proportion of Biological Indicators by Geographic Area in 2024
Table 66. Fuze Medical Recent Developments
Table 67. Matachana Corporation Information
Table 68. Matachana Description and Business Overview
Table 69. Matachana Biological Indicators Product
Table 70. Matachana Biological Indicators Revenue (US$ Million) and Gross Margin (2020-2025)
Table 71. Matachana Revenue Proportion of Biological Indicators by Product in 2024
Table 72. Matachana Revenue Proportion of Biological Indicators by Application in 2024
Table 73. Matachana Revenue Proportion of Biological Indicators by Geographic Area in 2024
Table 74. Matachana Recent Developments
Table 75. Hu-Friedy Corporation Information
Table 76. Hu-Friedy Description and Business Overview
Table 77. Hu-Friedy Biological Indicators Product
Table 78. Hu-Friedy Biological Indicators Revenue (US$ Million) and Gross Margin (2020-2025)
Table 79. Hu-Friedy Revenue Proportion of Biological Indicators by Product in 2024
Table 80. Hu-Friedy Revenue Proportion of Biological Indicators by Application in 2024
Table 81. Hu-Friedy Revenue Proportion of Biological Indicators by Geographic Area in 2024
Table 82. Hu-Friedy Recent Developments
Table 83. Advanced Sterilization Corporation Information
Table 84. Advanced Sterilization Description and Business Overview
Table 85. Advanced Sterilization Biological Indicators Product
Table 86. Advanced Sterilization Biological Indicators Revenue (US$ Million) and Gross Margin (2020-2025)
Table 87. Advanced Sterilization Revenue Proportion of Biological Indicators by Product in 2024
Table 88. Advanced Sterilization Revenue Proportion of Biological Indicators by Application in 2024
Table 89. Advanced Sterilization Revenue Proportion of Biological Indicators by Geographic Area in 2024
Table 90. Advanced Sterilization Recent Developments
Table 91. Bag Health Care Corporation Information
Table 92. Bag Health Care Description and Business Overview
Table 93. Bag Health Care Biological Indicators Product
Table 94. Bag Health Care Biological Indicators Revenue (US$ Million) and Gross Margin (2020-2025)
Table 95. Bag Health Care Revenue Proportion of Biological Indicators by Product in 2024
Table 96. Bag Health Care Revenue Proportion of Biological Indicators by Application in 2024
Table 97. Bag Health Care Revenue Proportion of Biological Indicators by Geographic Area in 2024
Table 98. Bag Health Care Recent Developments
Table 99. Terragene Corporation Information
Table 100. Terragene Description and Business Overview
Table 101. Terragene Biological Indicators Product
Table 102. Terragene Biological Indicators Revenue (US$ Million) and Gross Margin (2020-2025)
Table 103. Terragene Revenue Proportion of Biological Indicators by Product in 2024
Table 104. Terragene Revenue Proportion of Biological Indicators by Application in 2024
Table 105. Terragene Revenue Proportion of Biological Indicators by Geographic Area in 2024
Table 106. Terragene Recent Developments
Table 107. Andersen Corporation Information
Table 108. Andersen Description and Business Overview
Table 109. Andersen Biological Indicators Product
Table 110. Andersen Biological Indicators Revenue (US$ Million) and Gross Margin (2020-2025)
Table 111. Andersen Revenue Proportion of Biological Indicators by Product in 2024
Table 112. Andersen Revenue Proportion of Biological Indicators by Application in 2024
Table 113. Andersen Revenue Proportion of Biological Indicators by Geographic Area in 2024
Table 114. Andersen Recent Developments
Table 115. GKE Corporation Information
Table 116. GKE Description and Business Overview
Table 117. GKE Biological Indicators Product
Table 118. GKE Biological Indicators Revenue (US$ Million) and Gross Margin (2020-2025)
Table 119. GKE Revenue Proportion of Biological Indicators by Product in 2024
Table 120. GKE Revenue Proportion of Biological Indicators by Application in 2024
Table 121. GKE Revenue Proportion of Biological Indicators by Geographic Area in 2024
Table 122. GKE Recent Developments
Table 123. North America Biological Indicators Revenue by Country (2020-2025) & (US$ Million)
Table 124. North America Biological Indicators Revenue by Country (2026-2031) & (US$ Million)
Table 125. North America Biological Indicators Revenue by Type (2020-2025) & (US$ Million)
Table 126. North America Biological Indicators Revenue by Application (2020-2025) & (US$ Million)
Table 127. Asia-Pacific Biological Indicators Revenue by Region (2020-2025) & (US$ Million)
Table 128. Asia-Pacific Biological Indicators Revenue by Region (2026-2031) & (US$ Million)
Table 129. Asia-Pacific Biological Indicators Revenue by Type (2020-2025) & (US$ Million)
Table 130. Asia-Pacific Biological Indicators Revenue by Application (2020-2025) & (US$ Million)
Table 131. Europe Biological Indicators Revenue by Country (2020-2025) & (US$ Million)
Table 132. Europe Biological Indicators Revenue by Country (2026-2031) & (US$ Million)
Table 133. Europe Biological Indicators Revenue by Type (2020-2025) & (US$ Million)
Table 134. Europe Biological Indicators Revenue by Application (2020-2025) & (US$ Million)
Table 135. Latin America Biological Indicators Revenue by Country (2020-2025) & (US$ Million)
Table 136. Latin America Biological Indicators Revenue by Country (2026-2031) & (US$ Million)
Table 137. Latin America Biological Indicators Revenue by Type (2020-2025) & (US$ Million)
Table 138. Latin America Biological Indicators Revenue by Application (2020-2025) & (US$ Million)
Table 139. Middle East and Africa Biological Indicators Revenue by Country (2020-2025) & (US$ Million)
Table 140. Middle East and Africa Biological Indicators Revenue by Country (2026-2031) & (US$ Million)
Table 141. Middle East and Africa Biological Indicators Revenue by Type (2020-2025) & (US$ Million)
Table 142. Middle East and Africa Biological Indicators Revenue by Application (2020-2025) & (US$ Million)
Table 143. Biological Indicators Key Raw Materials, Industry Status and Trend
Table 144. Biological Indicators Key Raw Materials and Upstream Suppliers
Table 145. Biological Indicators Clients Status and Trend
Table 146. Biological Indicators Typical Clients
Table 147. Biological Indicators Distributors
Table 148. Biological Indicators Market Trends
Table 149. Biological Indicators Market Drivers
Table 150. Biological Indicators Market Challenges
Table 151. Biological Indicators Market Restraints
Table 152. Research Programs/Design for This Report
Table 153. Key Data Information from Secondary Sources
Table 154. Key Data Information from Primary Sources
List of Figures
Figure 1. Biological Indicators Product Picture
Figure 2. Global Biological Indicators Market Size by Type (US$ Million): 2020 VS 2024 VS 2031
Figure 3. Global Biological Indicators Revenue Market Share by Type in 2024 & 2031
Figure 4. Self-Contained Biological Indicator Product Picture
Figure 5. Biological Indicator Strip Product Picture
Figure 6. Global Biological Indicators Market Size by Application (US$ Million): 2020 VS 2024 VS 2031
Figure 7. Global Biological Indicators Revenue Market Share by Application in 2024 & 2031
Figure 8. Hospital
Figure 9. Pharma Companies
Figure 10. Others
Figure 11. Biological Indicators Report Years Considered
Figure 12. Global Biological Indicators Revenue, (US$ Million), 2020 VS 2024 VS 2031
Figure 13. Global Biological Indicators Market Size (2020-2031) & (US$ Million)
Figure 14. Global Biological Indicators Market Size Market Share by Region: 2024 Versus 2031
Figure 15. Global Biological Indicators Revenue Market Share by Region (2020-2031)
Figure 16. Global Biological Indicators Revenue Market Share Forecast by Type (2020-2031)
Figure 17. Global Biological Indicators Revenue Market Share Forecast by Application (2020-2031)
Figure 18. Self-Contained Biological Indicator of Biological Indicators Revenue Market Share by Application, 2024 VS 2031
Figure 19. Biological Indicator Strip of Biological Indicators Revenue Market Share by Application, 2024 VS 2031
Figure 20. Biological Indicators Revenue Share by Company (2024)
Figure 21. Biological Indicators Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024
Figure 22. Self-Contained Biological Indicator Revenue Proportion by Company in 2024
Figure 23. Biological Indicator Strip Revenue Proportion by Company in 2024
Figure 24. North America Biological Indicators Revenue 2020-2031 (US$ Million)
Figure 25. North America Biological Indicators Revenue Market Share by Type (2020-2025)
Figure 26. North America Biological Indicators Revenue Market Share by Application (2020-2025)
Figure 27. Asia-Pacific Biological Indicators Revenue 2020-2031 (US$ Million)
Figure 28. Asia-Pacific Biological Indicators Revenue Market Share by Region (2020-2031)
Figure 29. Asia-Pacific Biological Indicators Revenue Market Share by Type (2020-2025)
Figure 30. Asia-Pacific Biological Indicators Revenue Market Share by Application (2020-2025)
Figure 31. Europe Biological Indicators Revenue Growth Rate 2020-2031 (US$ Million)
Figure 32. Europe Biological Indicators Revenue Market Share by Country (2020-2031)
Figure 33. Europe Biological Indicators Revenue Market Share by Type (2020-2025)
Figure 34. Europe Biological Indicators Revenue Market Share by Application (2020-2025)
Figure 35. Latin America Biological Indicators Revenue Growth Rate 2020-2031 (US$ Million)
Figure 36. Latin America Biological Indicators Revenue Market Share by Country (2020-2031)
Figure 37. Latin America Biological Indicators Revenue Market Share by Type (2020-2025)
Figure 38. Latin America Biological Indicators Revenue Market Share by Application (2020-2025)
Figure 39. Middle East and Africa Biological Indicators Revenue Growth Rate 2020-2031 (US$ Million)
Figure 40. Middle East and Africa Biological Indicators Revenue Market Share by Country (2020-2031)
Figure 41. Middle East and Africa Biological Indicators Revenue Market Share by Type (2020-2025)
Figure 42. Middle East and Africa Biological Indicators Revenue Market Share by Application (2020-2025)
Figure 43. Biological Indicators Supply Chain (Upstream and Downstream Market)
Figure 44. Global Production Market Share of Biological Indicators Raw Materials by Region in 2024
Figure 45. Biological Indicators Distribution Channels
Figure 46. Global Biological Indicators Percentage 2020-2031: Indirect Sales VS Direct Sales
Figure 47. Global Biological Indicators Percentage 2020-2031: Online Sales VS Offline Sales
Figure 48. Bottom-up and Top-down Approaches for This Report
Figure 49. Data Triangulation
Figure 50. Key Executives Interviewed
